Sixty-one percent of respondents said that they “replaced” prescription opioids and/or benzodiazepines with medical cannabis – a finding that is consistent with several other studies.
“Increased medical and recreational storefront dispensary counts are associated with reduced opioid related mortality rates during the study period. These associations appear particularly strong for deaths related to synthetic opioids such as fentanyl.”
“The findings of this study add to the growing body of evidence that easier access to cannabis for patients with pain may reduce opioid use and partially offset expenditures for both public and private drug plans.”
“Over time, individuals who continued consuming cannabis within this longitudinal study reported lower pain severity and pain interference scores, as well as improved quality of life and general health symptoms scores.”
“The results show that the majority of U.S. consumers perceive cannabis (as CBD, hemp, marijuana, and THC) as having medical uses and view the potential for abuse of cannabis as less than for commonly prescribed medications and alcohol.”
Researchers reported: “For the first time, we show a statistically significant negative association between recreational access to cannabis and OTC sleep aid sales.”
Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to study.
Researchers concluded, “Our findings are consistent with prior surveys of American and Canadian marijuana users in which substitution of marijuana for opioids was prevalent due to better symptom management and fewer adverse and withdrawal effects.”